Brochure
12 Oct 2023
Celltrion brochure
brochure.celltrion.com
Content provided by our supplier
Celltrion
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
Other Content from Celltrion (2)
-
News Bora Pharmaceuticals partners with Celltrion to crack the APAC market
Bora Pharmaceuticals, the international cGMP CDMO producing specialised pharmaceutical products such as sterile and non-sterile ophthalmics and nasal sprays for clinical use, is partnering with Celltrion Asia Pacific, subsidiary of Celltrion Group Inc.
-
News The Korean biopharma market: Incentivizing innovation
With new drug approvals hitting a record high in 2021 and unprecedented number of out-licensing deals closed in 2020, Korean pharmaceutical companies and CDMO’s are poised for significant market growth [i].